AAV-mediated local delivery of interferon-β for the treatment of retinoblastoma in preclinical models

NeuroMolecular Medicine

Volumn 11, Issue 1, 2009, Pages 43-52

  Shih, Chie Schin ^a,b   Laurie, Nikia ^a   Holzmacher, Jeremy ^a   Spence, Yunyu ^a   Nathwani, Amit C ^c   Davidoff, Andrew M ^a,d   Dyer, Michael A ^a,d  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

AAV; Gene therapy; Interferon ; Retinoblastoma

Indexed keywords

BETA INTERFERON; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER THERAPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RETINITIS; RETINOBLASTOMA; TARGET CELL; TUMOR CELL; TUMOR XENOGRAFT; VIRAL GENE THERAPY; ADENO ASSOCIATED VIRUS; ANIMAL; CANCER TRANSPLANTATION; CHILD; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; METABOLISM; METHODOLOGY; SPRAGUE DAWLEY RAT; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CHILD; DEPENDOVIRUS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTERFERON-BETA; NEOPLASM TRANSPLANTATION; RATS; RATS, SPRAGUE-DAWLEY; RETINOBLASTOMA; TRANSPLANTATION, HETEROLOGOUS;

EID: 65249152968     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12017-009-8059-0     Document Type: Article

References (51)

1. RR Ali MB Reichel M De Alwis N Kanuga C Kinnon RJ Levinsky DM Hunt SS Bhattacharya AJ Thrasher 1998 Adeno-associated virus gene transfer to mouse retina Human Gene Therapy 9 1 81 86 9458245 10.1089/hum.1998.9.1-81 1:CAS:528:DyaK1cXlsV2jsQ%3D%3D
2. RR Ali MB Reichel AJ Thrasher RJ Levinsky C Kinnon N Kanuga DM Hunt SS Bhattacharya 1996 Gene transfer into the mouse retina mediated by an adeno-associated viral vector Human Molecular Genetics 5 5 591 594 8733124 10.1093/hmg/5.5.591 1:CAS:528:DyaK28XivVOjtr4%3D (Pubitemid 26141271)
3. J Bennett AM Maguire AV Cideciyan M Schnell E Glover V Anand TS Aleman N Chirmule AR Gupta Y Huang GP Gao WC Nyberg J Tazelaar J Hughes JM Wilson SG Jacobson 1999 Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina Proceedings of the National Academy of Sciences of the USA 96 17 9920 9925 10449795 10.1073/pnas.96.17.9920 1:CAS:528:DyaK1MXlsVymurw%3D (Pubitemid 29398833)
4. PA Campochiaro 2002 Gene therapy for retinal and choroidal diseasesEn Expert Opinion on Biological Therapy 2 537 544 12079489 10.1517/14712598.2.5.537 1:CAS:528:DC%2BD38Xls1CqsL4%3D (Pubitemid 34716736)
5. P Chevez-Barrios M Chintagumpala W Mieler E Paysse M Boniuk C Kozinetz MY Hurwitz RL Hurwitz 2005 Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir Journal of Clinical Oncology 23 31 7927 7935 16258092 10.1200/JCO.2004.00.1883 1:CAS:528:DC%2BD2MXht1CqsL7N (Pubitemid 46657392)
6. P Chevez-Barrios MY Hurwitz K Louie KT Marcus VN Holcombe P Schafer CE Aguilar-Cordova RL Hurwitz 2000 Metastatic and nonmetastatic models of retinoblastoma American Journal of Pathology 157 4 1405 1412 11021842 1:STN:280:DC%2BD3M%2FgvFSnsQ%3D%3D
7. EA Choi H Lei DJ Maron R Mick J Barsoum QC Yu, et al. 2004 Combined 5-fluorouracil/systemic interferon-beta gene therapy results in long-term survival in mice with established colorectal liver metastases Clinical Cancer Research 10 1535 1544 14977858 10.1158/1078-0432.CCR-0040-03 1:CAS:528:DC%2BD2cXhsVGjt7Y%3D (Pubitemid 38365250)
8. Coppin, C., Porzsolt, F., Awa, A., Kumpf, J., Coldman, A., & Wilt, T. (2005). Immunotherapy for advanced renal cell cancer. Cochrane Database of Systematic Reviews, (1), CD001425.
9. AM Davidoff JT Gray CY Ng Y Zhang J Zhou Y Spence Y Bakar AC Nathwani 2005 Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models Molecular Therapy 11 6 875 888 15922958 10.1016/j.ymthe.2004.12.022 1:CAS:528:DC%2BD2MXks1ajsLo%3D (Pubitemid 40724106)
10. NS Dejneka TS Rex J Bennett 2003 Gene therapy and animal models for retinal disease Developments in Ophthalmology 37 188 198 12876838 10.1159/000072047 1:CAS:528:DC%2BD3sXnvVSisrg%3D
11. SD Der A Zhou BR Williams RH Silverman 1998 Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays Proceedings of the National Academy of Sciences of the USA 95 26 15623 15628 9861020 10.1073/pnas.95.26.15623 1:CAS:528: DyaK1MXhvFeisg%3D%3D (Pubitemid 29018750)
12. PV Dickson NL Hagedorn JB Hamner CH Fraga CY Ng CF Stewart AM Davidoff 2007 Interferon beta-mediated vessel stabilization improves delivery and efficacy of systemically administered topotecan in a murine neuroblastoma model Journal of Pediatric Surgery 42 1 160 165 17208558 10.1016/j.jpedsurg.2006.09. 052 discussion 165 (Pubitemid 46037729)
13. A Dinculescu L Glushakova SH Min WW Hauswirth 2005 Adeno-associated virus-vectored gene therapy for retinal disease Human Gene Therapy 16 6 649 663 15960597 10.1089/hum.2005.16.649 1:CAS:528:DC%2BD2MXltFymt7k%3D (Pubitemid 40864266)
14. G Dranoff 2004 Cytokines in cancer pathogenesis and cancer therapy Nature Reviews Cancer 4 1 11 22 14708024 10.1038/nrc1252 1:CAS:528: DC%2BD2cXos1Wjtg%3D%3D (Pubitemid 38111131)
15. L Dudus V Anand GM Acland SJ Chen JM Wilson KJ Fisher AM Maguire J Bennett 1999 Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV Vision Research 39 15 2545 2553 10396623 10.1016/S0042-6989(98)00308-3 1:STN:280:DyaK1MzisV2ntw%3D%3D (Pubitemid 29197300)
16. MA Dyer CL Cepko 2000 p57(Kip2) regulates progenitor cell proliferation and amacrine interneuron development in the mouse retina Development 127 16 3593 3605 10903183 1:CAS:528:DC%2BD3cXmsFKitb0%3D
17. MA Dyer CL Cepko 2001 p27Kip1 and p57Kip2 regulate proliferation in distinct retinal progenitor cell populations Journal of Neuroscience 21 4259 4271 11404411 1:CAS:528:DC%2BD3MXktlKls7Y%3D
18. S Einhorn D Grander 1996 Why do so many cancer patients fail to respond to interferon therapy? Journal of Interferon and Cytokine Research 16 4 275 281 9162520 1:CAS:528:DyaK28XisFOktro%3D 10.1089/jir.1996.16.275
19. S Einhorn H Strander 1993 Interferon treatment of human malignancies-a short review Medical Oncology and Tumor Pharmacotherapy 10 1-2 25 29 7505041 1:STN:280:DyaK2c%2FotFKksA%3D%3D
20. EN Fish S Uddin M Korkmaz B Majchrzak BJ Druker LC Platanias 1999 Activation of a CrkL-stat5 signaling complex by type I interferons Journal of Biological Chemistry 274 2 571 573 9872990 10.1074/jbc.274.2.571 1:CAS:528:DyaK1MXmtFGgsw%3D%3D (Pubitemid 29058019)
21. S Folliot D Briot H Conrath N Provost Y Cherel P Moullier F Rolling 2003 Sustained tetracycline-regulated transgene expression in vivo in rat retinal ganglion cells using a single type 2 adeno-associated viral vector Journal of Gene Medicine 5 6 493 501 12797114 10.1002/jgm.367 1:CAS:528: DC%2BD3sXlsleqtL4%3D (Pubitemid 40310392)
22. AD Gibson 2002 Updated meta analysis finds that interferon-alpha improves progression-free and overall survival in low-grade non-Hodgkin's lymphoma when administered with chemotherapy that contains anthracycline or mitoxantrone Clinical Lymphoma 3 82 84 12435280
23. J Greil M Gramatzki R Burger R Marschalek M Peltner U Trautmann TE Hansen-Hagge CR Bartram GH Fey K Stehr, et al. 1994 The acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7 British Journal Haematology 86 2 275 283 10.1111/j.1365-2141.1994.tb04726.x 1:STN:280:DyaK2c3lslCrtg%3D%3D
24. J Guy X Qi N Muzyczka WW Hauswirth 1999 Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve Archives of Ophthalmology 117 7 929 937 10408459 1:CAS:528:DyaK1MXkvFarsbs%3D
25. BH Hayden TG Murray IU Scott N Cicciarelli E Hernandez W Feuer L Fulton JM O'Brien 2000 Subconjunctival carboplatin in retinoblastoma: impact of tumor burden and dose schedule Archives of Ophthalmology 118 11 1549 1554 11074812 1:STN:280:DC%2BD3M%2FisFGlug%3D%3D
26. SK Hendren I Prabakaran DG Buerk G Karakousis M Feldman F Spitz C Menon DL Fraker 2004 Interferon-beta gene therapy improves survival in an immunocompetent mouse model of carcinomatosis Surgery 135 427 436 15041967 10.1016/j.surg.2003.08.015 (Pubitemid 38453498)
27. MY Hurwitz KT Marcus P Chevez-Barrios K Louie E Aguilar-Cordova RL Hurwitz 1999 Suicide gene therapy for treatment of retinoblastoma in a murine model Human Gene Therapy 10 3 441 448 10048396 10.1089/10430349950018887 1:CAS:528:DyaK1MXht1eltLY%3D (Pubitemid 29097322)
28. J Kirkwood 2002 Cancer immunotherapy: The interferon-alpha experience Seminars in Oncology 29 3 Suppl 7 18 26 12068384 10.1053/sonc.2002.33078 1:CAS:528:DC%2BD38Xltlaqtrk%3D
29. JM Kirkwood AA Tarhini 2003 Adjuvant high-dose interferon-alpha therapy for high-risk melanoma Forum (Genova) 13 2 127 140 quiz 187-188
30. NA Laurie JK Gray J Zhang M Leggas M Relling M Egorin C Stewart MA Dyer 2005 Topotecan combination chemotherapy in two new rodent models of retinoblastoma Clinical Cancer Research 11 20 7569 7578 16243833 10.1158/1078-0432.CCR-05-0849 1:CAS:528:DC%2BD2MXhtFartbnM (Pubitemid 41507720)
31. S Li T Tokuyama J Yamamoto M Koide N Yokota H Namba 2005 Potent bystander effect in suicide gene therapy using neural stem cells transduced with herpes simplex virus thymidine kinase gene Oncology 69 6 503 508 16424680 10.1159/000091032 1:CAS:528:DC%2BD28XhtFSntbY%3D
32. FQ Liang TS Aleman NS Dejneka L Dudus KJ Fisher AM Maguire SG Jacobson J Bennett 2001 Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa Molecular Therapy 4 5 461 472 11708883 10.1006/mthe.2001.0473 1:CAS:528:DC%2BD38XhvFGqurs%3D (Pubitemid 33100284)
33. Ludwig, H. (2004). Supportive therapies in the management of myeloma. Oncology (Williston Park), 18, 295-296, 298.
34. W Lu IJ Fidler Z Dong 1999 Eradication of primary murine fibrosarcomas and induction of systemic immunity by adenovirus-mediated interferon beta gene therapy Cancer Research 59 5202 5208 10537298 1:CAS:528:DyaK1MXmvFelsL0%3D
35. RC McFall TW Sery M Makadon 1977 Characterization of a new continuous cell line derived from a human retinoblastoma Cancer Research 37 4 1003 1010 844036 1:STN:280:DyaE2s7js1ajuw%3D%3D
36. TG Murray N Cicciarelli JM O'Brien E Hernandez RL Mueller BJ Smith W Feuer 1997 Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma Archives of Ophthalmology 115 10 1286 1290 9338675 1:CAS:528:DyaK2sXmvFyguro%3D (Pubitemid 27435567)
37. AC Nathwani A Davidoff H Hanawa JF Zhou EF Vanin AW Nienhuis 2001 Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA Blood 97 5 1258 1265 11222368 10.1182/blood.V97.5.1258 1:CAS:528:DC%2BD3MXhs12ltrc%3D (Pubitemid 32183747)
38. A Naumova C Sapienza 1994 The genetics of retinoblastoma, revisited American Journal of Human Genetics 54 2 264 273 8304343 1:STN:280: DyaK2c7js1Crtw%3D%3D
39. LM Pfeffer CA Dinarello RB Herberman BR Williams EC Borden R Bordens MR Walter TL Nagabhushan PP Trotta S Pestka 1998 Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons Cancer Research 58 12 2489 2499 9635566 1:CAS:528:DyaK1cXktVajtrY%3D
40. XQ Qin N Tao A Dergay P Moy S Fawell A Davis, et al. 1998 Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice Proceedings of the National Academy of Sciences of the USA 95 14411 14416 9826714 10.1073/pnas.95.24.14411 1:CAS:528: DyaK1cXns1GlsLo%3D (Pubitemid 28549381)
41. Ries, L. A. G., Smith, M. A., Gurney, J. G., Linet, M., Tamra, T., Young, J. L., & Bunin, G. (1999). Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. Bethesda, MD, NIH Pub. No. 99-4649.
42. C Rodriguez-Galindo MW Wilson BG Haik TE Merchant CA Billups N Shah A Cain J Langston M Lipson LE Kun CB Pratt 2003 Treatment of intraocular retinoblastoma with vincristine and carboplatin Journal of Clinical Oncology 21 10 2019 2025 12743157 10.1200/JCO.2003.09.103 1:CAS:528:DC%2BD2cXptlCktr8%3D (Pubitemid 46606392)
43. AZ Rohatiner WM Gregory B Peterson E Borden P Solal-Celigny A Hagenbeek, et al. 2005 Meta-analysis to evaluate the role of interferon in follicular lymphoma Journal of Clinical Oncology 23 2215 2223 15684317 10.1200/JCO.2005.06. 146 1:CAS:528:DC%2BD2MXjsVyiu7k%3D (Pubitemid 46218713)
44. F Rolling 2004 Recombinant AAV-mediated gene transfer to the retina: Gene therapy perspectives Gene Therapy 11 Suppl 1 S26 S32 15454954 10.1038/sj.gt.3302366 1:CAS:528:DC%2BD2cXnvFCgs7c%3D (Pubitemid 39359444)
45. VK Sondak 2002 How does interferon work? Does it even matter? Cancer 95 5 947 949 12209676 10.1002/cncr.10779 (Pubitemid 34925342)
46. EM Surace A Auricchio 2003 Adeno-associated viral vectors for retinal gene transfer Progress in Retinal and Eye Research 22 705 719 14575721 10.1016/S1350-9462(03)00052-1 1:CAS:528:DC%2BD3sXot1GlsLo%3D (Pubitemid 37298045)
47. KR Van Quill PK Dioguardi CT Tong JA Gilbert TM Aaberg Jr HE Grossniklaus HF Edelhauser JM O'Brien 2005 Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma Ophthalmology 112 6 1151 1158 15885791 10.1016/j.ophtha.2004.11.060 (Pubitemid 40797475)
48. IA Voutsadakis 2000 Interferon-alpha and the pathogenesis of myeloproliferative disorders Medical Oncology 17 249 257 11114703 10.1007/BF02782189 1:STN:280:DC%2BD3M7gtlOguw%3D%3D
49. PD Wadhwa SP Zielske JC Roth CB Ballas JE Bowman SL Gerson 2002 Cancer gene therapy: Scientific basis Annual Review of Medicine 53 437 452 11818484 10.1146/annurev.med.53.082901.104039 1:CAS:528:DC%2BD38Xitl2mt7g%3D (Pubitemid 34177890)
50. J Yoshida M Mizuno T Wakabayashi 2004 Interferon-beta gene therapy for cancer: Basic research to clinical application Cancer Science 95 858 865 15546502 10.1111/j.1349-7006.2004.tb02194.x 1:CAS:528:DC%2BD2MXot1OksA%3D%3D (Pubitemid 40045519)
51. CC Zhu MA Dyer M Uchikawa H Kondoh OV Lagutin G Oliver 2002 Six3-mediated auto repression and eye development requires its interaction with members of the Groucho-related family of co-repressors Development 129 12 2835 2849 12050133 1:CAS:528:DC%2BD38XlsVyqtbo%3D